2023
Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults
February 2, 2023
Texas CARES researchers analyzed breakthrough COVID-19 infections after vaccination among Texas CARES participants. Their findings were published in The Journal of Infectious Diseases. Read the article here.
Breakthrough COVID-19 cases occur in 7.5% of vaccinated Texas participants, according to UTHealth Houston survey
February 7, 2023
Breakthrough COVID-19 infections after vaccination occurred in 7.5% of Texans surveyed, and higher odds were associated with Hispanic ethnicity, larger household size, rural versus urban living, type of vaccination, and multiple comorbidities, according to findings from UTHealth Houston School of Public Health, published Feb. 2 in the Journal of Infectious Diseases. Read the article here.
SARS-CoV-2 Serostatus and COVID-19 Illness Characteristics by Variant Time Period in Non-Hospitalized Children and Adolescents
April 30, 2023
Texas CARES researchers analyzed COVID-19 variant symptoms among Texas CARES participants ages 5-19. Their findings were published in Children by MDPI. Read the article here.
Long-term immune response to SARS-CoV-2 infection and vaccination in children and adolescents
October 24, 2023
The Texas CARES team examined now long antibodies last in children and adolescents. Findings were published in the journal Pediatric Research. Read the article here.
Children retain COVID-19 antibodies for up to a year, according to UTHealth Houston findings
October 24, 2023
Children had antibodies from a COVID-19 infection or vaccination for up to 12 months, suggesting they may have some protection from the virus for at least a year, according to new findings from UTHealth Houston researchers. Read the article here.
Incidence of SARS-CoV-2 breakthrough infections after vaccination in adults: A population-based survey through March 1, 2023
November 29, 2023
The Texas CARES team provided an update to previous findings covering breakthrough COVID-19 infections in a letter to the editor published in Open Forum Infectious Diseases. Read the article here.